Biotech & Pharma insider buying

Drug developers and pharmaceutical companies. Insider buying here is unusually informative and unusually risky: management sees trial data long before the market does, and a single readout can move the stock by half.

Buys · 90d

496

open-market

Bought · 90d

$488.1M

insider spend

Companies

114

with buying

Insiders

202

distinct buyers

Open-market purchases

Code P only, past 90 days, newest first.

Open screener →

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Insider	Role	Type	Shares	Price	Value	Δ Own	Filing
Sep 28	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	3,000	$101.70	$305.1K	+0.4%	Open the original filing on SEC.gov
Sep 28	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	1,500	$98.88	$148.3K	+0.2%	Open the original filing on SEC.gov
Sep 28	CTTH	Ctt Pharmaceutical…	Ctt Pharmaceutical…	CEO	PBUY	3,400	$0.055	$187	+<0.1%	Open the original filing on SEC.gov
Sep 25	ACOG	Alpha Cognition Inc.	Opaleye Management Inc.	10% Owner	PBUY	13,426	$8.47	$113.7K	+0.4%	Open the original filing on SEC.gov
Sep 25	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	2,176	$99.60	$216.7K	+0.3%	Open the original filing on SEC.gov
Sep 25	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	3,324	$98.87	$328.6K	+0.5%	Open the original filing on SEC.gov
Sep 25	DMRA	Damora Therapeutics, Inc.	Jarrett Jennifer	Director, President and…	PBUY	12,500	$20.23	$252.9K	+2.5%	Open the original filing on SEC.gov
Sep 24	ACOG	Alpha Cognition Inc.	Opaleye Management Inc.	10% Owner	PBUY	18,337	$8.57	$157.1K	+0.6%	Open the original filing on SEC.gov
Sep 24	ANIX	Anixa Biosciences Inc	Kumar Amit	Chief Executive Officer	PBUY	7,000	$2.78	$19.5K	+1.1%	Open the original filing on SEC.gov
Sep 24	ANIX	Anixa Biosciences Inc	Baskies Arnold M	Director	PBUY	5,000	$2.76	$13.8K	+3.7%	Open the original filing on SEC.gov
Sep 24	ANNX	Annexon, Inc.	Love Douglas	President and CEO	PBUY	26,065	$3.83	$99.8K	+7.1%	Open the original filing on SEC.gov
Sep 24	PHIO	Phio Pharmaceuticals Corp.	Bradford Patricia A	Director	PBUY	6,500	$1.01	$6.6K	+11.3%	Open the original filing on SEC.gov
Sep 24	CMPX	Compass Therapeutics, Inc.	Lerner Neil	Chief Accounting Officer	PBUY	2,500	$1.14	$2.9K	+0.6%	Open the original filing on SEC.gov
Sep 23	ADAG	Adagene Inc.	Tam Man Kin	Chief Financial Officer	PBUY	2,000	$3.00	$6K	+20.0%	Open the original filing on SEC.gov
Sep 23	ANIX	Anixa Biosciences Inc	Titterton Lewis H jr	Director	PBUY	49,036	$2.69	$131.9K	+4.9%	Open the original filing on SEC.gov
Sep 23	BCDA	BioCardia, Inc.	Altman Peter	President and CEO	PBUY	1,900	$1.05	$2K	+0.5%	Open the original filing on SEC.gov
Sep 23	GRCE	Grace Therapeutics, Inc.	Opaleye Management Inc.	10% Owner	PBUY	5,318	$2.10	$11.2K	+0.2%	Open the original filing on SEC.gov
Sep 23	INBX	Inhibrx Biosciences, Inc.	Kayyem Jon Faiz	Director	PBUY	5,000	$100.00	$500K	+1.2%	Open the original filing on SEC.gov
Sep 22	ENGN	enGene Therapeutics Inc.	Grossman William	Interim Chief Medical…	PBUY	5,102	$1.97	$10.1K	—	Open the original filing on SEC.gov
Sep 22	PHIO	Phio Pharmaceuticals Corp.	Bitterman Robert J	Chairman, Pres. & CEO	PBUY	2,000	$1.03	$2.1K	+0.5%	Open the original filing on SEC.gov
Sep 22	BFRG	BullFrog AI Holdings, Inc.	Singh Vininder	Chief Executive Officer	PBUY	75,000	$0.5989	$44.9K	+3.2%	Open the original filing on SEC.gov
Sep 22	BFRG	BullFrog AI Holdings, Inc.	Blacher Joshua	Chief Financial Officer	PBUY	50,000	$0.5285	$26.4K	+333.3%	Open the original filing on SEC.gov
Sep 22	CTTH	Ctt Pharmaceutical…	Ctt Pharmaceutical…	CEO	PBUY	10,100	$0.045	$455	+1.0%	Open the original filing on SEC.gov
Sep 21	GRCE	Grace Therapeutics, Inc.	Opaleye Management Inc.	10% Owner	PBUY	9,771	$2.10	$20.5K	+0.3%	Open the original filing on SEC.gov
Sep 21	ETRA	Electra Therapeutics, Inc.	Gordon Carl L	Director, 10% Owner	PBUY	1M	$15.00	$15M	+131.9%	Open the original filing on SEC.gov
Sep 21	ETRA	Electra Therapeutics, Inc.	Gordon Carl L	Director, 10% Owner	PBUY	333,333	$15.00	$5M	+7.0%	Open the original filing on SEC.gov
Sep 21	ETRA	Electra Therapeutics, Inc.	Orbimed Advisors Llc	Director, 10% Owner	PBUY	1M	$15.00	$15M	+131.9%	Open the original filing on SEC.gov
Sep 21	ETRA	Electra Therapeutics, Inc.	Orbimed Advisors Llc	Director, 10% Owner	PBUY	333,333	$15.00	$5M	+7.0%	Open the original filing on SEC.gov
Sep 21	CYBN	Cybin INC.	Halstead Michael	Chief Executive Officer	PBUY	100,000	$13.47	$1.3M	+145.8%	Open the original filing on SEC.gov
Sep 18	JUSH	Jushi Holdings Inc.	Cacioppo James	Chief Executive Officer	PBUY	20	$0.51	$10	0.0%	Open the original filing on SEC.gov
Sep 18	PRTA	Prothena Corp Public Ltd…	Scully William P	10% Owner	PBUY	100,000	$8.43	$843.5K	+12.1%	Open the original filing on SEC.gov
Sep 17	AIM	AIM ImmunoTech Inc.	Equels Thomas K	CEO & President	PBUY	24,000	$0.208	$5K	+23.3%	Open the original filing on SEC.gov
Sep 16	TENX	Tenax Therapeutics, INC.	Doogan Declan	Director	PBUY	53,000	$1.92	$101.8K	+2,331%	Open the original filing on SEC.gov
Sep 16	INBX	Inhibrx Biosciences, Inc.	Kayyem Jon Faiz	Director	PBUY	5,000	$100.00	$500K	+1.2%	Open the original filing on SEC.gov
Sep 16	AIM	AIM ImmunoTech Inc.	Equels Thomas K	CEO & President	PBUY	11,000	$0.21	$2.3K	+12.0%	Open the original filing on SEC.gov
Sep 16	ADAG	Adagene Inc.	Luo Peter	Chief Executive Officer	PBUY	20,290	$3.15	$64K	+29.7%	Open the original filing on SEC.gov
Sep 16	INM	InMed Pharmaceuticals Inc.	ADAR1 Capital Management…	10% Owner	PBUY	8,340	$1.29	$10.8K	+0.9%	Open the original filing on SEC.gov
Sep 16	ACOG	Alpha Cognition Inc.	Opaleye Management Inc.	10% Owner	PBUY	27,141	$8.40	$228K	+0.9%	Open the original filing on SEC.gov
Sep 16	ACOG	Alpha Cognition Inc.	Opaleye Management Inc.	10% Owner	PBUY	53,029	$8.57	$454.6K	+1.7%	Open the original filing on SEC.gov
Sep 16	CTTH	Ctt Pharmaceutical…	Ctt Pharmaceutical…	CEO	PBUY	10,900	$0.048	$523	+0.1%	Open the original filing on SEC.gov
Sep 15	LFVN	Lifevantage Corp	Lewis Darwin	Director	PBUY◷	976	$6.22	$6.1K	+0.7%	Open the original filing on SEC.gov
Sep 15	INM	InMed Pharmaceuticals Inc.	ADAR1 Capital Management…	10% Owner	PBUY	54,256	$1.30	$70.4K	+6.5%	Open the original filing on SEC.gov
Sep 15	ACOG	Alpha Cognition Inc.	Opaleye Management Inc.	10% Owner	PBUY	3,375	$8.54	$28.8K	+0.1%	Open the original filing on SEC.gov
Sep 15	PHIO	Phio Pharmaceuticals Corp.	Bradford Patricia A	Director	PBUY	12,000	$1.03	$12.4K	+26.3%	Open the original filing on SEC.gov
Sep 15	AIM	AIM ImmunoTech Inc.	Equels Thomas K	CEO & President	PBUY	22,000	$0.221	$4.9K	+31.5%	Open the original filing on SEC.gov
Sep 15	TENX	Tenax Therapeutics, INC.	Giordano Christopher…	CEO	PBUY	4,850	$1.82	$8.8K	+28.0%	Open the original filing on SEC.gov
Sep 15	NTHI	Neonc Technologies…	Heshmatpour Amir F	CEO, President	PBUY	35,000	$3.30	$115.4K	+1.1%	Open the original filing on SEC.gov
Sep 14	INM	InMed Pharmaceuticals Inc.	ADAR1 Capital Management…	10% Owner	PBUY	28,505	$1.29	$36.9K	+3.6%	Open the original filing on SEC.gov
Sep 14	ACOG	Alpha Cognition Inc.	Opaleye Management Inc.	10% Owner	PBUY	40,373	$8.70	$351.1K	+1.3%	Open the original filing on SEC.gov
Sep 14	NTHI	Neonc Technologies…	Heshmatpour Amir F	CEO, President	PBUY	15,000	$3.96	$59.4K	+0.5%	Open the original filing on SEC.gov
Sep 14	NTHI	Neonc Technologies…	Garnett Keithly	CFO	PBUY	257	$3.89	$1K	+0.1%	Open the original filing on SEC.gov
Sep 14	NTHI	Neonc Technologies…	Chen Thomas C	CEO	PBUY	5,242	$3.82	$20K	+27.2%	Open the original filing on SEC.gov
Sep 14	NAMS	NewAmsterdam Pharma Co…	Davidson Michael H.	Chief Executive Officer	PBUY	10,000	$22.65	$226.5K	+1.3%	Open the original filing on SEC.gov
Sep 14	AIM	AIM ImmunoTech Inc.	Equels Thomas K	CEO & President	PBUY	5,900	$0.219	$1.3K	+9.2%	Open the original filing on SEC.gov
Sep 14	HUMA	Humacyte, Inc.	Jones Keith Anthony	Director	PBUY	10,000	$0.562	$5.6K	+25.0%	Open the original filing on SEC.gov
Sep 14	MAIA	MAIA Biotechnology, Inc.	Vitoc Vlad	Chief Executive Officer	PBUY	73,000	$1.37	$100K	+7.5%	Open the original filing on SEC.gov
Sep 11	TENX	Tenax Therapeutics, INC.	Giordano Christopher…	CEO	PBUY	6,000	$1.88	$11.3K	+53.0%	Open the original filing on SEC.gov
Sep 11	TENX	Tenax Therapeutics, INC.	Staab Thomas R II	Chief Financial Officer	PBUY	5,675	$1.94	$11K	+56.8%	Open the original filing on SEC.gov
Sep 11	NTHI	Neonc Technologies…	Chen Thomas C	CEO	PBUY	5,556	$3.60	$20K	+40.5%	Open the original filing on SEC.gov
Sep 11	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	1,493	$65.95	$98.5K	+0.3%	Open the original filing on SEC.gov
Sep 11	NTHI	Neonc Technologies…	Heshmatpour Amir F	CEO, President	PBUY	37,000	$3.67	$135.6K	+1.2%	Open the original filing on SEC.gov
Sep 10	ONMD	OneMedNet Corp	Yu Jeffrey	Chief Medical Officer	PBUY	142,857	$0.63	$90K	+1.6%	Open the original filing on SEC.gov
Sep 10	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	1,631	$66.80	$108.9K	+0.3%	Open the original filing on SEC.gov
Sep 10	ANIX	Anixa Biosciences Inc	Kumar Amit	Chief Executive Officer	PBUY	3,000	$2.75	$8.3K	+0.4%	Open the original filing on SEC.gov
Sep 10	ANIX	Anixa Biosciences Inc	Titterton Lewis H jr	Director	PBUY	10,000	$2.73	$27.3K	+1.0%	Open the original filing on SEC.gov
Sep 10	MAIA	MAIA Biotechnology, Inc.	Guerrero Ramiro	Director	PBUY	37,595	$1.32	$49.5K	+5.1%	Open the original filing on SEC.gov
Sep 10	ANIX	Anixa Biosciences Inc	Kumar Amit	Chief Executive Officer	PBUY	5,000	$2.76	$13.8K	+0.8%	Open the original filing on SEC.gov
Sep 10	RLMD	Relmada Therapeutics, INC.	Traversa Sergio	Chief Executive Officer	PBUY	100,000	$4.10	$410K	+7.1%	Open the original filing on SEC.gov
Sep 10	RLMD	Relmada Therapeutics, INC.	Shenouda Maged	Chief Financial Officer	PBUY	79,800	$4.25	$339.2K	+8.7%	Open the original filing on SEC.gov
Sep 10	CTTH	Ctt Pharmaceutical…	Ctt Pharmaceutical…	CEO	PBUY	3,500	$0.05	$175	+<0.1%	Open the original filing on SEC.gov
Sep 9	MGX	Metagenomi Therapeutics,…	Reid Laurence	Director	PBUY	117	$1.18	$138	+0.6%	Open the original filing on SEC.gov
Sep 9	MGX	Metagenomi Therapeutics,…	Reid Laurence	Director	PBUY	19,883	$1.17	$23.3K	—	Open the original filing on SEC.gov
Sep 9	TYRA	Tyra Biosciences, Inc.	Verjee Rehan	Director	PBUY	971.89	$20.58	$20K	—	Open the original filing on SEC.gov
Sep 9	RLMD	Relmada Therapeutics, INC.	Traversa Sergio	Chief Executive Officer	PBUY	100,000	$4.18	$418K	+7.7%	Open the original filing on SEC.gov
Sep 9	RLMD	Relmada Therapeutics, INC.	Shenouda Maged	Chief Financial Officer	PBUY	120,200	$4.20	$504.8K	+15.0%	Open the original filing on SEC.gov
Sep 9	GRCE	Grace Therapeutics, Inc.	Opaleye Management Inc.	10% Owner	PBUY	5,836	$2.09	$12.2K	+0.2%	Open the original filing on SEC.gov
Sep 9	GRCE	Grace Therapeutics, Inc.	Kohli Prashant	Chief Executive Officer	PBUY	100,000	$2.14	$214K	+468.2%	Open the original filing on SEC.gov
Sep 9	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	3,097	$68.71	$212.8K	+0.6%	Open the original filing on SEC.gov
Sep 8	JUSH	Jushi Holdings Inc.	Arsenault Denis J.	10% Owner	PBUY	15,100	$0.62	$9.4K	+0.2%	Open the original filing on SEC.gov
Sep 8	CYBN	Cybin INC.	Glavine Paul	Chief Growth Officer	PBUY	100,000	$12.47	$1.2M	+2.4%	Open the original filing on SEC.gov
Sep 8	CYBN	Cybin INC.	So Eric H. L.	Executive Chair	PBUY	100,000	$12.39	$1.2M	+2.3%	Open the original filing on SEC.gov
Sep 8	GRCE	Grace Therapeutics, Inc.	Opaleye Management Inc.	10% Owner	PBUY	9,393	$2.10	$19.7K	+0.3%	Open the original filing on SEC.gov
Sep 8	ALMS	Alumis INC.	Akkaraju Srinivas	Director	PBUY	273,290	$10.63	$2.9M	+13.5%	Open the original filing on SEC.gov
Sep 8	ALMS	Alumis INC.	Akkaraju Srinivas	Director	PBUY	273,291	$10.63	$2.9M	+5.9%	Open the original filing on SEC.gov
Sep 8	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	471	$69.37	$32.7K	+<0.1%	Open the original filing on SEC.gov
Sep 8	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	3,390	$68.74	$233K	+0.6%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Kayyem Jon Faiz	Director	PBUY	5,000	$113.52	$567.6K	+1.2%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Forsyth Douglas	Director	PBUY	2,500	$114.65	$286.6K	+1.1%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	9,681	$112.28	$1.1M	+1.3%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	1,219	$111.88	$136.4K	+0.2%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	500	$108.24	$54.1K	+<0.1%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	1,100	$107.12	$117.8K	+0.1%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	6,605	$100.64	$664.7K	+0.9%	Open the original filing on SEC.gov
Sep 8	INBX	Inhibrx Biosciences, Inc.	Lappe Mark	Chief Executive Officer	PBUY	5,895	$99.29	$585.3K	+0.8%	Open the original filing on SEC.gov
Sep 7	TLX	Telix Pharmaceuticals Ltd	Smith Darren Charlton	Group Chief Financial…	PBUY	2,071	$9.66	$20K	+17.4%	Open the original filing on SEC.gov
Sep 4	CYBN	Cybin INC.	So Eric H. L.	Executive Chair	PBUY	100,000	$12.09	$1.2M	+2.3%	Open the original filing on SEC.gov
Sep 4	ALMS	Alumis INC.	Akkaraju Srinivas	Director	PBUY	220,070	$11.17	$2.5M	+11.9%	Open the original filing on SEC.gov
Sep 4	ALMS	Alumis INC.	Akkaraju Srinivas	Director	PBUY	220,070	$11.17	$2.5M	+4.9%	Open the original filing on SEC.gov
Sep 4	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	2,100	$68.98	$144.9K	+0.4%	Open the original filing on SEC.gov
Sep 4	SLGL	Sol-Gel Technologies Ltd.	Opaleye Management Inc.	10% Owner	PBUY	918	$69.52	$63.8K	+0.2%	Open the original filing on SEC.gov

INBXPBUY$305.1K

Lappe Mark · Chief Executive…Sep 28

3,000 sh @ $101.70 · +0.4% own

INBXPBUY$148.3K

Lappe Mark · Chief Executive…Sep 28

1,500 sh @ $98.88 · +0.2% own

CTTHPBUY$187

Ctt Pharmaceutical… · CEOSep 28

3,400 sh @ $0.055 · +<0.1% own

ACOGPBUY$113.7K

Opaleye Management Inc. · 10% OwnerSep 25

13,426 sh @ $8.47 · +0.4% own

INBXPBUY$216.7K

Lappe Mark · Chief Executive…Sep 25

2,176 sh @ $99.60 · +0.3% own

INBXPBUY$328.6K

Lappe Mark · Chief Executive…Sep 25

3,324 sh @ $98.87 · +0.5% own

DMRAPBUY$252.9K

Jarrett Jennifer · Director, Presiden…Sep 25

12,500 sh @ $20.23 · +2.5% own

ACOGPBUY$157.1K

Opaleye Management Inc. · 10% OwnerSep 24

18,337 sh @ $8.57 · +0.6% own

ANIXPBUY$19.5K

Kumar Amit · Chief Executive…Sep 24

7,000 sh @ $2.78 · +1.1% own

ANIXPBUY$13.8K

Baskies Arnold M · DirectorSep 24

5,000 sh @ $2.76 · +3.7% own

ANNXPBUY$99.8K

Love Douglas · President and CEOSep 24

26,065 sh @ $3.83 · +7.1% own

PHIOPBUY$6.6K

Bradford Patricia A · DirectorSep 24

6,500 sh @ $1.01 · +11.3% own

CMPXPBUY$2.9K

Lerner Neil · Chief Accounting…Sep 24

2,500 sh @ $1.14 · +0.6% own

ADAGPBUY$6K

Tam Man Kin · Chief Financial…Sep 23

2,000 sh @ $3.00 · +20.0% own

ANIXPBUY$131.9K

Titterton Lewis H jr · DirectorSep 23

49,036 sh @ $2.69 · +4.9% own

BCDAPBUY$2K

Altman Peter · President and CEOSep 23

1,900 sh @ $1.05 · +0.5% own

GRCEPBUY$11.2K

Opaleye Management Inc. · 10% OwnerSep 23

5,318 sh @ $2.10 · +0.2% own

INBXPBUY$500K

Kayyem Jon Faiz · DirectorSep 23

5,000 sh @ $100.00 · +1.2% own

ENGNPBUY$10.1K

Grossman William · Interim Chief…Sep 22

5,102 sh @ $1.97

PHIOPBUY$2.1K

Bitterman Robert J · Chairman, Pres. &…Sep 22

2,000 sh @ $1.03 · +0.5% own

BFRGPBUY$44.9K

Singh Vininder · Chief Executive…Sep 22

75,000 sh @ $0.5989 · +3.2% own

BFRGPBUY$26.4K

Blacher Joshua · Chief Financial…Sep 22

50,000 sh @ $0.5285 · +333.3% own

CTTHPBUY$455

Ctt Pharmaceutical… · CEOSep 22

10,100 sh @ $0.045 · +1.0% own

GRCEPBUY$20.5K

Opaleye Management Inc. · 10% OwnerSep 21

9,771 sh @ $2.10 · +0.3% own

ETRAPBUY$15M

Gordon Carl L · Director, 10%…Sep 21

1M sh @ $15.00 · +131.9% own

ETRAPBUY$5M

Gordon Carl L · Director, 10%…Sep 21

333,333 sh @ $15.00 · +7.0% own

ETRAPBUY$15M

Orbimed Advisors Llc · Director, 10%…Sep 21

1M sh @ $15.00 · +131.9% own

ETRAPBUY$5M

Orbimed Advisors Llc · Director, 10%…Sep 21

333,333 sh @ $15.00 · +7.0% own

CYBNPBUY$1.3M

Halstead Michael · Chief Executive…Sep 21

100,000 sh @ $13.47 · +145.8% own

JUSHPBUY$10

Cacioppo James · Chief Executive…Sep 18

20 sh @ $0.51 · 0.0% own

PRTAPBUY$843.5K

Scully William P · 10% OwnerSep 18

100,000 sh @ $8.43 · +12.1% own

AIMPBUY$5K

Equels Thomas K · CEO & PresidentSep 17

24,000 sh @ $0.208 · +23.3% own

TENXPBUY$101.8K

Doogan Declan · DirectorSep 16

53,000 sh @ $1.92 · +2,331% own

INBXPBUY$500K

Kayyem Jon Faiz · DirectorSep 16

5,000 sh @ $100.00 · +1.2% own

AIMPBUY$2.3K

Equels Thomas K · CEO & PresidentSep 16

11,000 sh @ $0.21 · +12.0% own

ADAGPBUY$64K

Luo Peter · Chief Executive…Sep 16

20,290 sh @ $3.15 · +29.7% own

INMPBUY$10.8K

ADAR1 Capital Management… · 10% OwnerSep 16

8,340 sh @ $1.29 · +0.9% own

ACOGPBUY$228K

Opaleye Management Inc. · 10% OwnerSep 16

27,141 sh @ $8.40 · +0.9% own

ACOGPBUY$454.6K

Opaleye Management Inc. · 10% OwnerSep 16

53,029 sh @ $8.57 · +1.7% own

CTTHPBUY$523

Ctt Pharmaceutical… · CEOSep 16

10,900 sh @ $0.048 · +0.1% own

LFVNPBUY◷$6.1K

Lewis Darwin · DirectorSep 15

976 sh @ $6.22 · +0.7% own

INMPBUY$70.4K

ADAR1 Capital Management… · 10% OwnerSep 15

54,256 sh @ $1.30 · +6.5% own

ACOGPBUY$28.8K

Opaleye Management Inc. · 10% OwnerSep 15

3,375 sh @ $8.54 · +0.1% own

PHIOPBUY$12.4K

Bradford Patricia A · DirectorSep 15

12,000 sh @ $1.03 · +26.3% own

AIMPBUY$4.9K

Equels Thomas K · CEO & PresidentSep 15

22,000 sh @ $0.221 · +31.5% own

TENXPBUY$8.8K

Giordano Christopher… · CEOSep 15

4,850 sh @ $1.82 · +28.0% own

NTHIPBUY$115.4K

Heshmatpour Amir F · CEO, PresidentSep 15

35,000 sh @ $3.30 · +1.1% own

INMPBUY$36.9K

ADAR1 Capital Management… · 10% OwnerSep 14

28,505 sh @ $1.29 · +3.6% own

ACOGPBUY$351.1K

Opaleye Management Inc. · 10% OwnerSep 14

40,373 sh @ $8.70 · +1.3% own

NTHIPBUY$59.4K

Heshmatpour Amir F · CEO, PresidentSep 14

15,000 sh @ $3.96 · +0.5% own

NTHIPBUY$1K

Garnett Keithly · CFOSep 14

257 sh @ $3.89 · +0.1% own

NTHIPBUY$20K

Chen Thomas C · CEOSep 14

5,242 sh @ $3.82 · +27.2% own

NAMSPBUY$226.5K

Davidson Michael H. · Chief Executive…Sep 14

10,000 sh @ $22.65 · +1.3% own

AIMPBUY$1.3K

Equels Thomas K · CEO & PresidentSep 14

5,900 sh @ $0.219 · +9.2% own

HUMAPBUY$5.6K

Jones Keith Anthony · DirectorSep 14

10,000 sh @ $0.562 · +25.0% own

MAIAPBUY$100K

Vitoc Vlad · Chief Executive…Sep 14

73,000 sh @ $1.37 · +7.5% own

TENXPBUY$11.3K

Giordano Christopher… · CEOSep 11

6,000 sh @ $1.88 · +53.0% own

TENXPBUY$11K

Staab Thomas R II · Chief Financial…Sep 11

5,675 sh @ $1.94 · +56.8% own

NTHIPBUY$20K

Chen Thomas C · CEOSep 11

5,556 sh @ $3.60 · +40.5% own

SLGLPBUY$98.5K

Opaleye Management Inc. · 10% OwnerSep 11

1,493 sh @ $65.95 · +0.3% own

NTHIPBUY$135.6K

Heshmatpour Amir F · CEO, PresidentSep 11

37,000 sh @ $3.67 · +1.2% own

ONMDPBUY$90K

Yu Jeffrey · Chief Medical…Sep 10

142,857 sh @ $0.63 · +1.6% own

SLGLPBUY$108.9K

Opaleye Management Inc. · 10% OwnerSep 10

1,631 sh @ $66.80 · +0.3% own

ANIXPBUY$8.3K

Kumar Amit · Chief Executive…Sep 10

3,000 sh @ $2.75 · +0.4% own

ANIXPBUY$27.3K

Titterton Lewis H jr · DirectorSep 10

10,000 sh @ $2.73 · +1.0% own

MAIAPBUY$49.5K

Guerrero Ramiro · DirectorSep 10

37,595 sh @ $1.32 · +5.1% own

ANIXPBUY$13.8K

Kumar Amit · Chief Executive…Sep 10

5,000 sh @ $2.76 · +0.8% own

RLMDPBUY$410K

Traversa Sergio · Chief Executive…Sep 10

100,000 sh @ $4.10 · +7.1% own

RLMDPBUY$339.2K

Shenouda Maged · Chief Financial…Sep 10

79,800 sh @ $4.25 · +8.7% own

CTTHPBUY$175

Ctt Pharmaceutical… · CEOSep 10

3,500 sh @ $0.05 · +<0.1% own

MGXPBUY$138

Reid Laurence · DirectorSep 9

117 sh @ $1.18 · +0.6% own

MGXPBUY$23.3K

Reid Laurence · DirectorSep 9

19,883 sh @ $1.17

TYRAPBUY$20K

Verjee Rehan · DirectorSep 9

971.89 sh @ $20.58

RLMDPBUY$418K

Traversa Sergio · Chief Executive…Sep 9

100,000 sh @ $4.18 · +7.7% own

RLMDPBUY$504.8K

Shenouda Maged · Chief Financial…Sep 9

120,200 sh @ $4.20 · +15.0% own

GRCEPBUY$12.2K

Opaleye Management Inc. · 10% OwnerSep 9

5,836 sh @ $2.09 · +0.2% own

GRCEPBUY$214K

Kohli Prashant · Chief Executive…Sep 9

100,000 sh @ $2.14 · +468.2% own

SLGLPBUY$212.8K

Opaleye Management Inc. · 10% OwnerSep 9

3,097 sh @ $68.71 · +0.6% own

JUSHPBUY$9.4K

Arsenault Denis J. · 10% OwnerSep 8

15,100 sh @ $0.62 · +0.2% own

CYBNPBUY$1.2M

Glavine Paul · Chief Growth…Sep 8

100,000 sh @ $12.47 · +2.4% own

CYBNPBUY$1.2M

So Eric H. L. · Executive ChairSep 8

100,000 sh @ $12.39 · +2.3% own

GRCEPBUY$19.7K

Opaleye Management Inc. · 10% OwnerSep 8

9,393 sh @ $2.10 · +0.3% own

ALMSPBUY$2.9M

Akkaraju Srinivas · DirectorSep 8

273,290 sh @ $10.63 · +13.5% own

ALMSPBUY$2.9M

Akkaraju Srinivas · DirectorSep 8

273,291 sh @ $10.63 · +5.9% own

SLGLPBUY$32.7K

Opaleye Management Inc. · 10% OwnerSep 8

471 sh @ $69.37 · +<0.1% own

SLGLPBUY$233K

Opaleye Management Inc. · 10% OwnerSep 8

3,390 sh @ $68.74 · +0.6% own

INBXPBUY$567.6K

Kayyem Jon Faiz · DirectorSep 8

5,000 sh @ $113.52 · +1.2% own

INBXPBUY$286.6K

Forsyth Douglas · DirectorSep 8

2,500 sh @ $114.65 · +1.1% own

INBXPBUY$1.1M